Liraglutide biosimilar(Glenmark Pharmaceuticals) | Interleukin Related interleukin-related.com

Product Name :
Liraglutide biosimilar(Glenmark Pharmaceuticals)

Search keywords :
GLP-1R

drugId :
null

Target Vo:
Glucagon-like peptide 1 receptor

Target Vo Short Name :
GLP1R

Moa_Name:
Glucagon-like peptide 1 receptor modulators

First Approval Country :
India

First Approval Date Filter:
2024

Origin Company_Name :
Glenmark Pharmaceuticals Ltd

Active Company_Name :
Glenmark Pharmaceuticals Ltd

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cleaved PARP Rabbit mAb web
FEN1 (YP6039) Mouse mAb Purity
Caspase-10 Antibody: Caspase-10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Caspase-10. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts